Shrinking Sheena: Crossing the weight-loss plateaus

Posted by j0hn on February 27th, 2007 — in Xenical Top News

This column was supposed to be about the frustrations and anger I was feeling about being on a seemingly never-ending plateau.
It was supposed to detail the heartache, bellyaching and frustration I’ve felt as my body refuses to escape the nightmare that is the 250s.
It was supposed to […]

GlaxoSmithKline to launch a weight loss OTC drug

Posted by j0hn on February 20th, 2007 — in Xenical Top News

WASHINGTON: The U.S. Food and Drug Administration has recently given approval for a weight loss drug that can be sold across-the-counter and the drug, Alli, is expected to be available this year.
Alli (pronounced AL-eye) is the first OTC drug that can be used to shed weight and its manufacturer GlaxoSmithKline cautions that it is designed […]

With eating changes, diet drug will work

Posted by j0hn on February 19th, 2007 — in Xenical Top News

News staff writer
The FDA recently approved the weight-loss drug orlistat for over-the-counter sales under the brand name Alli, and it is scheduled to show up in stores this summer. The drug has been available by prescription for years under the brand name Xenical.
GlaxoSmithKline will manufacture Alli (pronounced like ally) as a blue pill at its […]

FDA Approves Alli™ (orlistat 60 Mg Capsules) Over-the-counter

Posted by j0hn on February 11th, 2007 — in Xenical Top News

GlaxoSmithKline [NYSE:GSK] Consumer Healthcare announces today that the US Food and Drug Administration (FDA) approved the weight-loss product orlistat 60 mg capsules for over-the-counter (OTC) use in the United States. GSK Consumer Healthcare will market OTC orlistat under the brand name alli ™ (pronounced AL-eye). Approved for use by overweight adults in conjunction with a […]

More Kids Having Weight-Loss Surgery

Posted by j0hn on February 5th, 2007 — in Xenical Top News

As the popularity of stomach surgery has skyrocketed among obese adults, a growing number of doctors are asking, “Why not children, too?”
For decades, the number of kids trying weight-loss surgery has been tiny. The operations themselves were risky, with a death rate of about 1 in 50. Children rarely got that fat, and when they […]

Sanofi’s Acomplia, first in class, may soon be one of a crowd - extended

Posted by j0hn on February 2nd, 2007 — in Xenical Top News

Sanofi-Aventis SA’s Acomplia may be losing a head start in the race to market a new type of weight-loss drug as Merck & Co. and Pfizer Inc. push rival products through their labs.
Paris-based Sanofi anticipated Acomplia would win US Food and Drug Administration approval last year. The FDA delayed a decision until April, giving the […]